Healthcare Capital Acquisition (HCAC) Stock Price, News & Analysis

Company Overview

Healthcare Capital Acquisition (NASDAQ: HCAC) is a special purpose acquisition company (SPAC), commonly referred to as a blank‑check company, formed to raise capital through a public listing and pursue one or more business combinations. As a SPAC, Healthcare Capital Acquisition does not operate commercial businesses of its own; instead it holds funds in trust while identifying and negotiating a merger, acquisition or other business combination with an operating company, with a stated focus on opportunities in the healthcare sector.

The firm’s primary activities include sourcing and evaluating potential targets in healthcare and life sciences, structuring transactions, and completing a business combination that would result in the target becoming a publicly listed company. Typical target areas for healthcare‑focused SPACs include biopharmaceuticals, medical device and diagnostics companies, healthcare services and technology platforms. Until a transaction is completed, the company’s principal “product” is access to capital and a public listing that can be used to facilitate growth or liquidity for private healthcare businesses.

Public filings and offering documents provide the most reliable detail about the company’s sponsors, board and executive team, transaction criteria and timelines; interested investors should review those materials for up‑to‑date information. Like other SPACs, Healthcare Capital Acquisition operates under a finite period to complete a business combination and may pursue targets in the U.S. and internationally depending on strategic fit. Because the company’s activities are transaction‑oriented, the nature of its operations and the markets it serves will be defined largely by the business it ultimately combines with.

Key Stats

• Today's Range: $10.08 to $10.09
• 50-Day Range: $10.03 to $10.10
• 52-Week Range: $9.91 to $10.10
• Volume: 109,163 shs
• Average Volume: 93,408 shs
• Market Capitalization: $376.43 million
• P/E Ratio: 201.80
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Healthcare Capital Acquisition Stock Analysis - MarketRank™

Healthcare Capital Acquisition scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Healthcare Capital Acquisition has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Healthcare Capital Acquisition has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Healthcare Capital Acquisition is 201.80, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.39.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Healthcare Capital Acquisition has been sold short.

Short Interest Ratio / Days to Cover

Healthcare Capital Acquisition has a short interest ratio ("days to cover") of 0.46, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Healthcare Capital Acquisition has recently decreased by 60.88%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Healthcare Capital Acquisition does not currently pay a dividend.

Dividend Growth

Healthcare Capital Acquisition does not have a long track record of dividend growth.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.44

News Sentiment

Healthcare Capital Acquisition has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Healthcare Capital Acquisition this week, compared to 1 article on an average week.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Healthcare Capital Acquisition insiders have not sold or bought any company stock.

Percentage Held by Insiders

26.34% of the stock of Healthcare Capital Acquisition is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

66.82% of the stock of Healthcare Capital Acquisition is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HCAC
• CIK: 2079013
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 201.80
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 37,307,000
• Free Float: N/A
• Market Cap: $376.43 million
• Optionable: N/A
• Beta: 0.41